Preventing avoidable central line-associated bloodstream infections: Implications for probiotic administration and surveillance

Am J Infect Control. 2016 Nov 1;44(11):1427-1428. doi: 10.1016/j.ajic.2016.07.029.

Authors

Sonja Skljarevski¹, Amanda Barner², Lou Ann Bruno-Murtha³

Affiliations

¹ Internal Medicine, Cambridge Health Alliance, Cambridge, MA.
² Clinical Pharmacy, Cambridge Health Alliance, Cambridge, MA. Electronic address: [email protected].
³ Internal Medicine, Cambridge Health Alliance, Cambridge, MA; Division of Infectious Diseases, Cambridge Health Alliance, Cambridge, MA; Harvard Medical School, Cambridge, MA.

PMID: 27810067
DOI: 10.1016/j.ajic.2016.07.029

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Bacteremia / prevention & control*
Catheter-Related Infections / prevention & control*
Diabetes Mellitus, Type 2 / blood
Diabetes Mellitus, Type 2 / microbiology
Diabetes Mellitus, Type 2 / therapy*
Enteral Nutrition*
Female
Humans
Lactobacillus
Probiotics / administration & dosage*